# Selenium Thyroid Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/selenium-thyroid-randomized-trial-evidence-review
Category: evidence-review
Summary: Selenium Thyroid Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are syste
Last reviewed: 2026-05-28
Reviewed by: Migaku Evidence Review
# Selenium Thyroid Randomized Trial: What the Evidence Says

## Quick Answer

Selenium Thyroid Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Photobiomodulation Therapy in Chronic Autoimmune Thyroiditis: A Systematic Review of Molecular Mechanisms and Clinical Applications | systematic review | 1 | 2026-03-26 | 10.3390/ijms27073007 |
| The caprices of a trace element: selenium’s considerable effects on Hashimoto’s thyroiditis, though few on Graves’ disease | research article | 4 | 2026-02-14 | 10.1530/ETJ-26-0009 |

## What The Sources Report

- As a result, many patients will experience ongoing autoimmunity, abnormal thyroid morphology, or residual symptoms after their hormone replacement is optimized. [Berisha-Muharremi Venera (2026); evidence level 1]
- In the thyroid gland, the increased perfusion may improve the viability of thyroid follicular cells, the synthesis of hormones, and tissue regeneration. [Berisha-Muharremi Venera (2026); evidence level 1]
- Se deficiency is linked to an increased risk of and progression of inflammatory diseases, especially chronic autoimmune thyroiditis (AIT), and primarily Hashimoto's thyroiditis (HT) and Graves' disease (GD). [Duntas Leonidas H (2026); evidence level 4]
- Se supplementation has been used in both conditions with evidence-based positive results in HT but questionable results in GD (,,). [Duntas Leonidas H (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For selenium thyroid randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Berisha-Muharremi Venera (2026). Photobiomodulation Therapy in Chronic Autoimmune Thyroiditis: A Systematic Review of Molecular Mechanisms and Clinical Applications. DOI: 10.3390/ijms27073007. PMCID: PMC13073973. PMID: 41977196. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13073973/
- Duntas Leonidas H (2026). The caprices of a trace element: selenium’s considerable effects on Hashimoto’s thyroiditis, though few on Graves’ disease. DOI: 10.1530/ETJ-26-0009. PMCID: PMC12927446. PMID: 41677203. License: https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Attribution-NonCommercial 4.0 International License..... https://pmc.ncbi.nlm.nih.gov/articles/PMC12927446/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.